Madrigal Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MDGL and other ETFs, options, and stocks.About MDGL
Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia.
CEOWilliam J. Sibold
CEOWilliam J. Sibold
Employees376
Employees376
HeadquartersWest Conshohocken, Pennsylvania
HeadquartersWest Conshohocken, Pennsylvania
Founded2011
Founded2011
Employees376
Employees376
MDGL Key Statistics
Market cap5.03B
Market cap5.03B
Price-Earnings ratio-11.53
Price-Earnings ratio-11.53
Dividend yield—
Dividend yield—
Average volume498.66K
Average volume498.66K
High today$236.65
High today$236.65
Low today$228.48
Low today$228.48
Open price$231.78
Open price$231.78
Volume422.26K
Volume422.26K
52 Week high$313.11
52 Week high$313.11
52 Week low$119.76
52 Week low$119.76
MDGL News
Investor's Business Daily 14h
Madrigal Pharmaceuticals Shows Improved Relative Strength; Still Shy Of Benchmark - Investor's Business DailyMadrigal Pharmaceuticals (MDGL) had its Relative Strength (RS) Rating upgraded from 61 to 71 Monday — a welcome improvement, but still below the 80 or higher sc...
Analyst ratings
80%
of 15 ratingsBuy
80%
Hold
13.3%
Sell
6.7%